Floatz logo

19 assets in Aggressive NK-Cell Leukemia

Therapeutic assets addressing Aggressive NK-Cell Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Aggressive NK-Cell Leukemia
The Affiliated Hospital of Xuzhou Medical UniversityP2B (60)
Anti-Cd56 Car T
Aggressive NK-Cell Leukemia
The Affiliated Hospital of Xuzhou Medical UniversityP2CCC (53)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Aggressive NK-Cell Leukemia
St. Jude Children's Research HospitalP2CCC (53)
Blinatumomab
Aggressive NK-Cell Leukemia
St. Jude Children's Research HospitalP2CCC (53)
cd45ra-depleted dli
Aggressive NK-Cell Leukemia
St. Jude Children's Research HospitalP2CCC (53)
Fludarabine
Aggressive NK-Cell Leukemia
The Affiliated Hospital of Xuzhou Medical UniversityP2CCC (53)
Melphalan
Aggressive NK-Cell Leukemia
St. Jude Children's Research HospitalP2CCC (53)
Mesna
Aggressive NK-Cell Leukemia
St. Jude Children's Research HospitalP2CCC (53)
Thiotepa
Aggressive NK-Cell Leukemia
St. Jude Children's Research HospitalP2CCC (53)
Immunoglobulin G1, Anti-(Human/Macaca Fascicularis/Macaca Mulatta Killer Cell Lectin-Like Receptor Klrd1) (Human Monoclonal Dr-01 ?1-Chain), Disulfide With Human Monoclonal Dr-01 ?-Chain, Dimer
Aggressive NK-Cell Leukemia
Dren BioP1/2CCC (48)
Adriamycin
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Brentuximab Vedotin
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Calaspargase Pegol
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Dexasone
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Etoposide
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Isocyclophosphamide
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Methotrexate
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Pralatraxate
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)
Prednisone
Aggressive NK-Cell Leukemia
New York Medical CollegeEarly P1C (39)